LT-002-158

What stands out

New approach in eczema

• Breaks down IRAK4, a relay inside cells for innate alarm signals

History

Earliest recorded event: Jun 13, 2024. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

• Nov 25, 2025Phase 1 trial completed · Eczema target not confirmedA Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers ClinicalTrials.gov NCT06082323
• Jun 4, 2025Phase 1/2 trial startedA Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis ClinicalTrials.gov NCT06931990
• Jun 13, 2024Phase 1 trial started · Eczema target not confirmedA Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers ClinicalTrials.gov NCT06082323

Sources

Trials

• NCT06082323Results paper: Goldburg SR, Strober BE, Payette MJ.
• NCT06931990